Your browser doesn't support javascript.
loading
NAFLD: Time to apply quantitation in liver biopsies as endpoints in clinical trials.
Forlano, Roberta; Mullish, Benjamin H; Maurice, James B; Thursz, Mark R; Goldin, Robert D; Manousou, Pinelopi.
Affiliation
  • Forlano R; Liver Unit/ Division of Digestive Diseases, Department of Metabolism, Digestion and Reproduction, Imperial College, London, UK.
  • Mullish BH; Liver Unit/ Division of Digestive Diseases, Department of Metabolism, Digestion and Reproduction, Imperial College, London, UK.
  • Maurice JB; Liver Unit/ Division of Digestive Diseases, Department of Metabolism, Digestion and Reproduction, Imperial College, London, UK.
  • Thursz MR; Liver Unit/ Division of Digestive Diseases, Department of Metabolism, Digestion and Reproduction, Imperial College, London, UK.
  • Goldin RD; Centre for Pathology, Department of Medicine, Imperial College, London, UK.
  • Manousou P; Liver Unit/ Division of Digestive Diseases, Department of Metabolism, Digestion and Reproduction, Imperial College, London, UK. Electronic address: p.manousou@imperial.ac.uk.
J Hepatol ; 74(1): 241-242, 2021 01.
Article in En | MEDLINE | ID: mdl-33012546
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Non-alcoholic Fatty Liver Disease Limits: Humans Language: En Journal: J Hepatol Journal subject: GASTROENTEROLOGIA Year: 2021 Type: Article Affiliation country: United kingdom
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Non-alcoholic Fatty Liver Disease Limits: Humans Language: En Journal: J Hepatol Journal subject: GASTROENTEROLOGIA Year: 2021 Type: Article Affiliation country: United kingdom